ArticleACS pharmacology & translational science2024

Aptamer Proteolysis-Targeting Chimeras (PROTACs): A Novel Strategy to Combat Drug Resistance in Estrogen Receptor α-Positive Breast Cancer.

Ying Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.